Abbvie Inc. vs Arrowhead Research Corporation
ABBV vs ARWR — side-by-side comparison from reported financials. ABBV leads 5, ARWR leads 5 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Arrowhead Research Corporation
ARWR · Healthcare
$62.75+3.31%Solid
| Metric | ABBV | ARWR |
|---|---|---|
| Price | $276.43 | $62.75 |
| Market cap | $488B | $8.86B |
| Revenue (TTM) | $64.4B | $669M |
| Revenue growth | +1.8% | +50.5% |
| Net margin | 9.8% | -47.8% |
| Free cash flow | $18.2B | -$75.1M |
| Net cash (debt) | ($56.2B) | $478M |
| 1-year price return | +19.8% | +74.0% |
| P/E | 77.4 | — |
| P/E vs own history (cheap-side %) | 23% | 85% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | -61% |
| Altman Z-score | 2.33 | 2.52 |
| CV checks passed | 9 of 11 | 5 of 11 |
| Employees | 57,000 | 711 |
Full résumé-style profiles: ABBV CV · ARWR CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.